Norway's Sovereign-Wealth Fund Hits $1 Trillion Value for First Time
You're either born a growth-stock investor, or you're not.
New Data for Epacadostat in Combination with KEYTRUDA® (pembrolizumab) Demonstrate Durable Responses in Patients with Advanced Melanoma
GeNeuro and Servier Announce Six-Month Results from CHANGE-MS Phase 2b Study in Multiple Sclerosis
Inside Secure Completes the Acquisition of Meontrust and Enters Security-as-a-Service Market